Low-dose ropeginterferon alfa-2b and peginterferon alfa-2a have comparable efficacy and tolerability in polycythemia vera. Article uri icon

Overview

publication date

  • September 19, 2025

Identity

PubMed Central ID

  • PMC13132618

Scopus Document Identifier

  • 105017037402

Digital Object Identifier (DOI)

  • 10.1016/j.leukres.2025.108110

PubMed ID

  • 41014693

Additional Document Info

volume

  • 158